Treloar C - Search Results

1

The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.

Fortier E, Alavi M, Micallef M, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Bruneau J, Grebely J; ETHOS Study Group. Fortier E, et al. Among authors: treloar c. Int J Drug Policy. 2015 Nov;26(11):1094-102. doi: 10.1016/j.drugpo.2015.06.001. Epub 2015 Jun 11. Int J Drug Policy. 2015. PMID: 26145482

2

Receiving a hepatitis C-positive diagnosis.

Hopwood M, Treloar C. Hopwood M, et al. Among authors: treloar c. Intern Med J. 2004 Sep-Oct;34(9-10):526-31. doi: 10.1111/j.1445-5994.2004.00639.x. Intern Med J. 2004. PMID: 15482264

3

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

Doab A, Treloar C, Dore GJ. Doab A, et al. Among authors: treloar c. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S313-20. doi: 10.1086/427446. Clin Infect Dis. 2005. PMID: 15768340

4

Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales.

Cao W, Treloar C. Cao W, et al. Among authors: treloar c. Drug Alcohol Rev. 2006 Sep;25(5):439-44. doi: 10.1080/09595230600891282. Drug Alcohol Rev. 2006. PMID: 16939939

5

The gendered context of initiation to injecting drug use: evidence for women as active initiates.

Bryant J, Treloar C. Bryant J, et al. Among authors: treloar c. Drug Alcohol Rev. 2007 May;26(3):287-93. doi: 10.1080/09595230701247731. Drug Alcohol Rev. 2007. PMID: 17454018

6

How can hepatitis C be prevented in the long term?

Mateu-Gelabert P, Treloar C, Calatayud VA, Sandoval M, Zurián JC, Maher L, Rhodes T, Friedman SR. Mateu-Gelabert P, et al. Among authors: treloar c. Int J Drug Policy. 2007 Oct;18(5):338-40. doi: 10.1016/j.drugpo.2007.06.001. Epub 2007 Jul 24. Int J Drug Policy. 2007. PMID: 17854720 Free PMC article.

7

The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.

Hopwood M, Treloar C. Hopwood M, et al. Among authors: treloar c. Int J Drug Policy. 2007 Oct;18(5):374-80. doi: 10.1016/j.drugpo.2006.12.018. Epub 2007 Jan 23. Int J Drug Policy. 2007. PMID: 17854725

8

Resilient coping: applying adaptive responses to prior adversity during treatment for hepatitis C infection.

Hopwood M, Treloar C. Hopwood M, et al. Among authors: treloar c. J Health Psychol. 2008 Jan;13(1):17-27. doi: 10.1177/1359105307084308. J Health Psychol. 2008. PMID: 18086714

9

Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice.

Treloar C, Laybutt B, Jauncey M, van Beek I, Lodge M, Malpas G, Carruthers S. Treloar C, et al. Int J Drug Policy. 2008 Feb;19(1):59-65. doi: 10.1016/j.drugpo.2007.01.005. Epub 2007 Feb 12. Int J Drug Policy. 2008. PMID: 18312820

10

Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: implications for hepatitis C treatment.

Brener L, Treloar CJ. Brener L, et al. Aust Health Rev. 2009 Feb;33(1):100-6. doi: 10.1071/ah090100. Aust Health Rev. 2009. PMID: 19203339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters